ArticleCancer immunology research2024

CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Robust and Systemic Immune-Mediated Antitumor Activity.

Naveen K Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.